4% lower revenue,
Less than 2% annual sales cancelled,
Less than 5% annual sales delayed
Underlying EBITDA more than current market cap,
Directors bought high 30s
Dropped from 40 to 10c is not justified.
- Forums
- ASX - By Stock
- COF
- Ann: Trading Update
Ann: Trading Update , page-42
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COF (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online